Symbols / PROK Stock $1.90 -2.06% ProKidney Corp.
PROK (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-16 | init | HC Wainwright & Co. | — → Buy | $12 |
| 2025-07-15 | main | UBS | Buy → Buy | $8 |
| 2025-07-14 | main | Guggenheim | Buy → Buy | $7 |
| 2025-07-09 | main | Citigroup | Buy → Buy | $9 |
| 2025-06-30 | down | B of A Securities | Neutral → Underperform | $1 |
| 2024-09-30 | init | JP Morgan | — → Neutral | — |
| 2024-09-10 | init | Guggenheim | — → Buy | $6 |
| 2024-09-04 | main | B of A Securities | Neutral → Neutral | $3 |
| 2024-06-10 | main | Jefferies | Buy → Buy | $6 |
| 2024-05-29 | main | B of A Securities | Neutral → Neutral | $4 |
| 2024-01-02 | down | B of A Securities | Buy → Neutral | $2 |
| 2023-07-25 | init | BTIG | — → Buy | $16 |
| 2022-12-21 | init | Jefferies | — → Buy | $15 |
| 2022-11-10 | init | Morgan Stanley | — → Equal-Weight | $13 |
| 2022-10-18 | init | UBS | — → Buy | $18 |
| 2022-10-14 | init | Citigroup | — → Buy | $16 |
| 2022-09-02 | init | Evercore ISI Group | — → Outperform | — |
- ProKidney hires ex-Shield CEO Greg Madison for rilparencel launch prep - Stock Titan Wed, 25 Mar 2026 07
- $PROK stock is down 12% today. Here's what we see in our data. - Quiver Quantitative Mon, 29 Dec 2025 08
- ProKidney (NASDAQ:PROK) Stock Price Up 9% - Should You Buy? - MarketBeat Fri, 17 Apr 2026 22
- ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright - Yahoo Finance Sat, 27 Dec 2025 08
- ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK) - Seeking Alpha Sat, 31 Jan 2026 08
- April 2026 Penny Stock Highlights - simplywall.st Fri, 03 Apr 2026 07
- ProKidney (PROK) Stock Live Trade (On the Radar) 2026-04-20 - Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Tây Ninh Mon, 20 Apr 2026 16
- ProKidney: What's Happening With PROK Stock? - Forbes Wed, 09 Jul 2025 07
- ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewswire Mon, 10 Nov 2025 08
- ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy? - Yahoo Finance Wed, 16 Jul 2025 07
- ProKidney (NASDAQ:PROK) Shares Up 5.9% - Here's Why - MarketBeat Mon, 30 Mar 2026 07
- Executive pay, governance on agenda at ProKidney (NASDAQ: PROK) vote - Stock Titan Fri, 17 Apr 2026 07
- ProKidney Is Soaring on Trial Results. How Should You Play Penny Stock PROK Here? - Yahoo Finance ue, 08 Jul 2025 07
- ProKidney Corp. (NASDAQ:PROK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat hu, 16 Apr 2026 06
- ProKidney (NASDAQ: PROK) CEO awarded stock options on 3,000,000 shares - Stock Titan ue, 03 Mar 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.89
+1075.00%
|
0.08
|
0.00
|
0.00
|
| Operating Revenue |
|
0.89
+1075.00%
|
0.08
|
0.00
|
0.00
|
| Operating Expense |
|
165.90
-9.72%
|
183.75
+21.27%
|
151.52
-0.97%
|
153.01
|
| Research And Development |
|
114.12
-10.61%
|
127.67
+19.64%
|
106.71
+30.02%
|
82.07
|
| Selling General And Administration |
|
51.78
-7.68%
|
56.08
+25.15%
|
44.81
-36.82%
|
70.94
|
| General And Administrative Expense |
|
51.78
-7.68%
|
56.08
+25.15%
|
44.81
-36.82%
|
70.94
|
| Other Gand A |
|
51.78
-7.68%
|
56.08
+25.15%
|
44.81
-36.82%
|
70.94
|
| Total Expenses |
|
165.90
-9.72%
|
183.75
+21.27%
|
151.52
-0.97%
|
153.01
|
| Operating Income |
|
-165.01
+10.16%
|
-183.68
-21.22%
|
-151.52
+0.97%
|
-153.01
|
| Total Operating Income As Reported |
|
-165.01
+10.16%
|
-183.68
-21.22%
|
-151.52
+0.97%
|
-153.01
|
| EBITDA |
|
-144.62
+8.75%
|
-158.49
-26.20%
|
-125.59
+12.78%
|
-143.99
|
| Normalized EBITDA |
|
-144.62
+8.75%
|
-158.49
-26.20%
|
-125.59
+12.78%
|
-143.99
|
| Reconciled Depreciation |
|
6.58
+21.04%
|
5.43
+40.98%
|
3.85
+26.91%
|
3.04
|
| EBIT |
|
-151.19
+7.77%
|
-163.92
-26.64%
|
-129.44
+11.96%
|
-147.02
|
| Net Income |
|
-68.99
-12.75%
|
-61.19
-72.51%
|
-35.47
+67.17%
|
-108.03
|
| Pretax Income |
|
-151.20
+7.77%
|
-163.93
-26.64%
|
-129.45
+12.08%
|
-147.24
|
| Net Non Operating Interest Income Expense |
|
13.81
-30.06%
|
19.74
-10.55%
|
22.07
+282.65%
|
5.77
|
| Interest Expense Non Operating |
|
0.00
-55.56%
|
0.01
-25.00%
|
0.01
-94.42%
|
0.21
|
| Net Interest Income |
|
13.81
-30.06%
|
19.74
-10.55%
|
22.07
+282.65%
|
5.77
|
| Interest Expense |
|
0.00
-55.56%
|
0.01
-25.00%
|
0.01
-94.42%
|
0.21
|
| Interest Income Non Operating |
|
13.81
-30.07%
|
19.75
-10.56%
|
22.08
+269.10%
|
5.98
|
| Interest Income |
|
13.81
-30.07%
|
19.75
-10.56%
|
22.08
+269.10%
|
5.98
|
| Tax Provision |
|
0.41
+169.23%
|
-0.60
-109.97%
|
6.00
+569.20%
|
0.90
|
| Tax Rate For Calcs |
|
0.00
+5150.00%
|
0.00
-98.10%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-151.61
+7.18%
|
-163.34
-20.59%
|
-135.45
+8.57%
|
-148.13
|
| Net Income From Continuing Operation Net Minority Interest |
|
-68.99
-12.75%
|
-61.19
-72.51%
|
-35.47
+67.17%
|
-108.03
|
| Net Income From Continuing And Discontinued Operation |
|
-68.99
-12.75%
|
-61.19
-72.51%
|
-35.47
+67.17%
|
-108.03
|
| Net Income Continuous Operations |
|
-151.61
+7.18%
|
-163.34
-20.59%
|
-135.45
+8.57%
|
-148.13
|
| Minority Interests |
|
82.63
-19.11%
|
102.15
+2.17%
|
99.98
+149.31%
|
40.10
|
| Normalized Income |
|
-68.99
-12.75%
|
-61.19
-72.51%
|
-35.47
+67.17%
|
-108.03
|
| Net Income Common Stockholders |
|
-68.99
-12.75%
|
-61.19
-72.51%
|
-35.47
+67.17%
|
-108.03
|
| Diluted EPS |
|
-0.52
+16.13%
|
-0.62
-8.77%
|
-0.57
-147.83%
|
-0.23
|
| Basic EPS |
|
-0.52
+16.13%
|
-0.62
-8.77%
|
-0.57
-147.83%
|
-0.23
|
| Basic Average Shares |
|
133.94
+36.79%
|
97.92
+58.66%
|
61.71
+0.28%
|
61.54
|
| Diluted Average Shares |
|
133.94
+36.79%
|
97.92
+58.66%
|
61.71
+0.28%
|
61.54
|
| Diluted NI Availto Com Stockholders |
|
-68.99
-12.75%
|
-61.19
-72.51%
|
-35.47
+67.17%
|
-108.03
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
335.57
-23.92%
|
441.07
+4.88%
|
420.55
-18.81%
|
518.00
|
| Current Assets |
|
280.68
-29.10%
|
395.88
+5.81%
|
374.15
-25.87%
|
504.72
|
| Cash Cash Equivalents And Short Term Investments |
|
270.02
-24.64%
|
358.29
-1.28%
|
362.95
-25.97%
|
490.25
|
| Cash And Cash Equivalents |
|
108.54
+9.50%
|
99.12
+63.43%
|
60.65
-87.63%
|
490.25
|
| Other Short Term Investments |
|
161.48
-37.69%
|
259.17
-14.27%
|
302.30
|
0.00
|
| Receivables |
|
1.13
-53.94%
|
2.45
+77.96%
|
1.38
|
0.00
|
| Accrued Interest Receivable |
|
1.13
-53.94%
|
2.45
+77.96%
|
1.38
|
0.00
|
| Prepaid Assets |
|
6.73
-57.12%
|
15.70
+59.98%
|
9.81
-25.00%
|
13.08
|
| Assets Held For Sale Current |
|
0.00
-100.00%
|
19.37
|
0.00
|
—
|
| Other Current Assets |
|
2.80
+3405.00%
|
0.08
+788.89%
|
0.01
-99.35%
|
1.38
|
| Total Non Current Assets |
|
54.90
+21.48%
|
45.19
-2.62%
|
46.41
+249.52%
|
13.28
|
| Net PPE |
|
54.90
+21.48%
|
45.19
-2.62%
|
46.41
+255.22%
|
13.06
|
| Gross PPE |
|
71.45
+27.08%
|
56.22
+4.02%
|
54.05
+204.12%
|
17.77
|
| Accumulated Depreciation |
|
-16.55
-50.04%
|
-11.03
-44.36%
|
-7.64
-62.32%
|
-4.71
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
1.41
+0.00%
|
1.41
-54.19%
|
3.07
|
0.00
|
| Buildings And Improvements |
|
21.09
+0.00%
|
21.09
-6.20%
|
22.49
|
0.00
|
| Machinery Furniture Equipment |
|
8.31
+28.22%
|
6.49
+42.94%
|
4.54
+38.96%
|
3.27
|
| Construction In Progress |
|
14.71
+500.94%
|
2.45
-72.01%
|
8.74
+441.57%
|
1.61
|
| Other Properties |
|
3.66
+23.49%
|
2.97
-30.40%
|
4.26
+80.94%
|
2.36
|
| Leases |
|
22.26
+2.02%
|
21.82
+99.29%
|
10.95
+3.92%
|
10.54
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
0.00
-100.00%
|
0.21
|
| Total Liabilities Net Minority Interest |
|
34.78
-11.80%
|
39.44
+34.98%
|
29.22
+123.76%
|
13.06
|
| Current Liabilities |
|
30.74
-15.12%
|
36.22
+44.65%
|
25.04
+130.28%
|
10.87
|
| Payables And Accrued Expenses |
|
17.83
-25.69%
|
24.00
+43.58%
|
16.71
+137.94%
|
7.03
|
| Payables |
|
0.94
-78.22%
|
4.32
-34.32%
|
6.57
+115.83%
|
3.04
|
| Accounts Payable |
|
0.94
-74.13%
|
3.63
-28.74%
|
5.10
+67.48%
|
3.04
|
| Current Accrued Expenses |
|
16.89
-14.17%
|
19.68
+94.03%
|
10.14
+154.84%
|
3.98
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
11.84
+3.35%
|
11.45
+52.30%
|
7.52
+124.14%
|
3.35
|
| Total Tax Payable |
|
0.00
-100.00%
|
0.68
-53.67%
|
1.47
|
0.00
|
| Income Tax Payable |
|
0.00
-100.00%
|
0.68
-53.67%
|
1.47
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
1.07
+40.00%
|
0.77
-4.73%
|
0.80
+62.88%
|
0.49
|
| Current Capital Lease Obligation |
|
1.07
+40.00%
|
0.77
-4.73%
|
0.80
+62.88%
|
0.49
|
| Total Non Current Liabilities Net Minority Interest |
|
4.04
+25.47%
|
3.22
-22.95%
|
4.18
+91.30%
|
2.18
|
| Long Term Debt And Capital Lease Obligation |
|
2.96
+19.99%
|
2.47
-31.55%
|
3.61
+89.40%
|
1.91
|
| Long Term Capital Lease Obligation |
|
2.96
+19.99%
|
2.47
-31.55%
|
3.61
+89.40%
|
1.91
|
| Tradeand Other Payables Non Current |
|
1.07
+43.58%
|
0.75
+31.69%
|
0.57
+104.32%
|
0.28
|
| Stockholders Equity |
|
-1,011.20
-1.63%
|
-994.95
+9.83%
|
-1,103.40
-0.62%
|
-1,096.62
|
| Common Stock Equity |
|
-1,011.20
-1.63%
|
-994.95
+9.83%
|
-1,103.40
-0.62%
|
-1,096.62
|
| Capital Stock |
|
0.03
+3.45%
|
0.03
+26.09%
|
0.02
-4.17%
|
0.02
|
| Common Stock |
|
0.03
+3.45%
|
0.03
+26.09%
|
0.02
-4.17%
|
0.02
|
| Share Issued |
|
141.81
+10.74%
|
128.05
+113.85%
|
59.88
-2.70%
|
61.54
|
| Ordinary Shares Number |
|
141.81
+10.74%
|
128.05
+113.85%
|
59.88
-2.70%
|
61.54
|
| Additional Paid In Capital |
|
258.55
+25.67%
|
205.74
+469.68%
|
36.11
+383.07%
|
7.48
|
| Retained Earnings |
|
-1,269.84
-5.74%
|
-1,200.85
-5.37%
|
-1,139.66
-3.22%
|
-1,104.12
|
| Gains Losses Not Affecting Retained Earnings |
|
0.06
-56.92%
|
0.13
+0.00%
|
0.13
|
0.00
|
| Minority Interest |
|
1,311.99
-6.06%
|
1,396.59
-6.57%
|
1,494.73
-6.67%
|
1,601.56
|
| Other Equity Adjustments |
|
0.06
-56.92%
|
0.13
+0.00%
|
0.13
|
—
|
| Total Equity Gross Minority Interest |
|
300.79
-25.11%
|
401.64
+2.63%
|
391.34
-22.50%
|
504.94
|
| Total Capitalization |
|
-1,011.20
-1.63%
|
-994.95
+9.83%
|
-1,103.40
-0.62%
|
-1,096.62
|
| Working Capital |
|
249.94
-30.51%
|
359.67
+3.02%
|
349.11
-29.31%
|
493.85
|
| Invested Capital |
|
-1,011.20
-1.63%
|
-994.95
+9.83%
|
-1,103.40
-0.62%
|
-1,096.62
|
| Total Debt |
|
4.04
+24.72%
|
3.24
-26.67%
|
4.41
+83.95%
|
2.40
|
| Capital Lease Obligations |
|
4.04
+24.72%
|
3.24
-26.67%
|
4.41
+83.95%
|
2.40
|
| Net Tangible Assets |
|
-1,011.20
-1.63%
|
-994.95
+9.83%
|
-1,103.40
-0.60%
|
-1,096.83
|
| Tangible Book Value |
|
-1,011.20
-1.63%
|
-994.95
+9.83%
|
-1,103.40
-0.60%
|
-1,096.83
|
| Limited Partnership Capital |
|
—
|
—
|
—
|
—
|
| Total Partnership Capital |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-120.12
+4.93%
|
-126.35
-40.28%
|
-90.07
-16.84%
|
-77.09
|
| Cash Flow From Continuing Operating Activities |
|
-120.12
+4.93%
|
-126.35
-40.28%
|
-90.07
-16.84%
|
-77.09
|
| Net Income From Continuing Operations |
|
-151.61
+7.18%
|
-163.34
-20.59%
|
-135.45
+8.57%
|
-148.13
|
| Depreciation Amortization Depletion |
|
6.58
+21.04%
|
5.43
+40.98%
|
3.85
+26.91%
|
3.04
|
| Depreciation And Amortization |
|
6.58
+21.04%
|
5.43
+40.98%
|
3.85
+26.91%
|
3.04
|
| Other Non Cash Items |
|
-0.03
+81.99%
|
-0.16
|
—
|
—
|
| Stock Based Compensation |
|
25.34
-13.74%
|
29.37
-4.78%
|
30.85
-58.58%
|
74.47
|
| Asset Impairment Charge |
|
0.32
-94.03%
|
5.32
|
0.00
|
0.00
|
| Operating Gains Losses |
|
-1.99
+71.38%
|
-6.94
-15.75%
|
-6.00
|
—
|
| Gain Loss On Investment Securities |
|
-3.42
+51.15%
|
-7.00
-16.23%
|
-6.02
|
—
|
| Gain Loss On Sale Of PPE |
|
1.43
+2455.36%
|
0.06
+143.48%
|
0.02
|
0.00
|
| Change In Working Capital |
|
1.28
-67.62%
|
3.96
-76.27%
|
16.67
+358.15%
|
-6.46
|
| Change In Receivables |
|
1.32
+223.13%
|
-1.07
+22.04%
|
-1.38
|
0.00
|
| Change In Prepaid Assets |
|
6.24
+204.72%
|
-5.96
-228.12%
|
4.65
+164.28%
|
-7.23
|
| Change In Payables And Accrued Expense |
|
-6.28
-157.13%
|
10.98
-18.04%
|
13.40
+1635.88%
|
0.77
|
| Change In Payable |
|
-6.28
-157.13%
|
10.98
-18.04%
|
13.40
+1635.88%
|
0.77
|
| Change In Account Payable |
|
-5.92
-151.06%
|
11.59
-0.40%
|
11.64
+2256.07%
|
0.49
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
—
|
| Investing Cash Flow |
|
103.97
+409.28%
|
20.41
+106.19%
|
-329.98
-18886.36%
|
-1.74
|
| Cash Flow From Continuing Investing Activities |
|
103.97
+409.28%
|
20.41
+106.19%
|
-329.98
-18886.36%
|
-1.74
|
| Net PPE Purchase And Sale |
|
-15.20
+48.50%
|
-29.51
+13.71%
|
-34.20
-1752.49%
|
-1.85
|
| Purchase Of PPE |
|
-15.20
+48.50%
|
-29.51
+13.71%
|
-34.20
-1752.49%
|
-1.85
|
| Sale Of PPE |
|
—
|
—
|
0.00
|
0.00
|
| Capital Expenditure |
|
-15.20
+48.50%
|
-29.51
+13.71%
|
-34.20
-1752.49%
|
-1.85
|
| Net Investment Purchase And Sale |
|
100.95
+102.20%
|
49.92
+116.88%
|
-295.79
|
0.00
|
| Purchase Of Investment |
|
-217.08
+33.01%
|
-324.02
+31.29%
|
-471.60
|
0.00
|
| Sale Of Investment |
|
318.02
-14.96%
|
373.95
+112.69%
|
175.82
|
0.00
|
| Net Other Investing Changes |
|
18.21
|
—
|
—
|
0.11
|
| Financing Cash Flow |
|
25.57
-82.29%
|
144.41
+1611.97%
|
-9.55
-101.74%
|
548.52
|
| Cash Flow From Continuing Financing Activities |
|
25.57
-82.29%
|
144.41
+1611.97%
|
-9.55
-101.74%
|
548.52
|
| Net Issuance Payments Of Debt |
|
-0.03
+51.85%
|
-0.05
-3.85%
|
-0.05
-62.50%
|
-0.03
|
| Issuance Of Debt |
|
—
|
0.00
|
0.00
-100.00%
|
35.00
|
| Repayment Of Debt |
|
-0.03
+51.85%
|
-0.05
-3.85%
|
-0.05
+99.85%
|
-35.03
|
| Long Term Debt Payments |
|
-0.03
+51.85%
|
-0.05
-3.85%
|
-0.05
-62.50%
|
-0.03
|
| Net Long Term Debt Issuance |
|
-0.03
+51.85%
|
-0.05
-3.85%
|
-0.05
-62.50%
|
-0.03
|
| Short Term Debt Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
35.00
|
| Short Term Debt Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-35.00
|
| Net Short Term Debt Issuance |
|
—
|
0.00
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
24.25
-83.20%
|
144.32
+1619.34%
|
-9.50
|
0.00
|
| Common Stock Payments |
|
0.00
|
0.00
+100.00%
|
-9.50
|
0.00
|
| Repurchase Of Capital Stock |
|
0.00
|
0.00
+100.00%
|
-9.50
|
0.00
|
| Proceeds From Stock Option Exercised |
|
1.35
+862.86%
|
0.14
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
548.55
|
| Changes In Cash |
|
9.42
-75.52%
|
38.47
+108.96%
|
-429.60
-191.46%
|
469.69
|
| Beginning Cash Position |
|
99.12
+63.43%
|
60.65
-87.63%
|
490.25
+2284.73%
|
20.56
|
| End Cash Position |
|
108.54
+9.50%
|
99.12
+63.43%
|
60.65
-87.63%
|
490.25
|
| Free Cash Flow |
|
-135.31
+13.18%
|
-155.86
-25.42%
|
-124.27
-57.43%
|
-78.94
|
| Income Tax Paid Supplemental Data |
|
—
|
0.07
-97.44%
|
2.86
+46.51%
|
1.95
|
| Change In Income Tax Payable |
|
-0.36
+41.54%
|
-0.61
-134.56%
|
1.76
+533.81%
|
0.28
|
| Change In Tax Payable |
|
-0.36
+41.54%
|
-0.61
-134.56%
|
1.76
+533.81%
|
0.28
|
| Common Stock Issuance |
|
24.25
-83.20%
|
144.32
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
24.25
-83.20%
|
144.32
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-18 View
- 10-K2026-03-18 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 8-K2026-02-02 View
- 8-K2026-01-12 View
- 42025-11-14 View
- 8-K2025-11-10 View
- 10-Q2025-11-10 View
- 8-K2025-10-17 View
- 8-K2025-08-12 View
- 10-Q2025-08-12 View
- 8-K2025-07-15 View
- 8-K2025-07-14 View
- 42025-07-11 View
- 42025-07-09 View
- 8-K2025-07-08 View
- 8-K2025-07-01 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|